ABEO 株価分析 — Abeona Therapeutics Inc (Healthcare >> Biotechnology)
ABEO に関するよくある質問
ABEOのPER(株価収益率)は?
Abeona Therapeutics Inc(ABEO)は現在PER 3.35倍で取引されています。
ABEOのROE(自己資本利益率)は?
Abeona Therapeutics IncのROEは45.63%です。
ABEOの配当利回りは?
Abeona Therapeutics Incの配当利回りは0.00%です。
ABEOの品質スコア(Quality Score)は?
当社のAIはABEOの総合財務品質を100点中62点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ABEOは今が買い時ですか?
当社AIのタイミングスコアは100点中89点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ABEOはどのセクターに属しますか?
Abeona Therapeutics IncはHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)
ABEO AI Analysis Summary
Our AI summary for ABEO: Abeona Therapeutics Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 3.35, ROE of 45.63%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 6.82
Price
0.43
(6.73%)
Day Change
|
|
|---|
ABEO, ファンダメンタルスコアはok ( ファンダメンタル = 62) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are ok , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
60% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
52
GOOD
|
| Magic Formula Rank by ROE |
52
GOOD
|
| Magic Formula Rank by ROIC |
47
GREAT
|
| Price | 6.82 |
| PBV / Sector |
2.51 / 44,022.72
|
| Earning Per Share | 1.24 |
| PE / Sector |
3.35 / 19.17
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 1.24
|
| Average 1M Daily Value |
8.29 M
|
| Average 1W Daily Value |
6.77 M
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-05 07:59:46 |
| Symbol | ABEO |
| Name | ABEONA THERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 57.00 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 364.20 / 9,586.08 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6555 Carnegie Avenue, Cleveland, OH, United States, 44103
Phone: 646 813 4701
Website: https://www.abeonatherapeutics.com
Employees: 226
Sector: Healthcare >> Biotechnology
Description: Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google